Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)

View source ↗

Summary

The NCI-sponsored clinical trial NCT04774289, now completed, compared the incidence of malignant peripheral nerve sheath tumors in people with Neurofibromatosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis 1, Peripheral Nerve Neoplasms, Malignant | Status: COMPLETED